{"id":"https://openalex.org/W4210695280","doi":"https://doi.org/10.1093/brain/awac016","title":"How patients with multiple sclerosis acquire disability","display_name":"How patients with multiple sclerosis acquire disability","publication_year":2022,"publication_date":"2022-01-28","ids":{"openalex":"https://openalex.org/W4210695280","doi":"https://doi.org/10.1093/brain/awac016","pmid":"https://pubmed.ncbi.nlm.nih.gov/35104840"},"language":"en","primary_location":{"id":"doi:10.1093/brain/awac016","doi":"https://doi.org/10.1093/brain/awac016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/brain/awac016","pdf_url":"https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac016/42358857/awac016.pdf","source":{"id":"https://openalex.org/S118357697","display_name":"Brain","issn_l":"0006-8950","issn":["0006-8950","1460-2156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac016/42358857/awac016.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025501697","display_name":"FRED D. LUBLIN","orcid":"https://orcid.org/0000-0001-5722-0475","observed_orcids":["https://orcid.org/0000-0001-5722-0475"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Fred D Lublin","raw_affiliation_strings":["The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai , New York, NY ,","The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai , New York, NY , USA"],"raw_orcid":"https://orcid.org/0000-0001-5722-0475","affiliations":[{"raw_affiliation_string":"The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai , New York, NY ,","institution_ids":["https://openalex.org/I98704320"]},{"raw_affiliation_string":"The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai , New York, NY , USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072651915","display_name":"Dieter Adrian H\u00e4ring","orcid":"https://orcid.org/0000-0001-5690-8710","observed_orcids":["https://orcid.org/0000-0001-5690-8710"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Dieter A H\u00e4ring","raw_affiliation_strings":["Novartis Pharma AG , Basel ,","Novartis Pharma AG , Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-5690-8710","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG , Basel ,","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG , Basel , Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053048489","display_name":"Habib Ganjgahi","orcid":"https://orcid.org/0000-0002-7332-9478","observed_orcids":["https://orcid.org/0000-0002-7332-9478"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Habib Ganjgahi","raw_affiliation_strings":["Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford , Oxford ,","Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-7332-9478","affiliations":[{"raw_affiliation_string":"Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford , Oxford ,","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069340593","display_name":"Alex Ocampo","orcid":"https://orcid.org/0000-0003-1967-039X","observed_orcids":["https://orcid.org/0000-0003-1967-039X"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alex Ocampo","raw_affiliation_strings":["Novartis Pharma AG , Basel ,","Novartis Pharma AG , Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-1967-039X","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG , Basel ,","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG , Basel , Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086096349","display_name":"Farhad Hatami","orcid":"https://orcid.org/0000-0002-0275-9243","observed_orcids":["https://orcid.org/0000-0002-0275-9243"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Farhad Hatami","raw_affiliation_strings":["Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford , Oxford ,","Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-0275-9243","affiliations":[{"raw_affiliation_string":"Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford , Oxford ,","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032103026","display_name":"Jelena \u010cuklina","orcid":"https://orcid.org/0000-0002-3837-9349","observed_orcids":["https://orcid.org/0000-0002-3837-9349","https://orcid.org/0000-0002-5220-8642"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Jelena \u010cuklina","raw_affiliation_strings":["Novartis Pharma AG , Basel ,","Novartis Pharma AG , Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-3837-9349","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG , Basel ,","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG , Basel , Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053207191","display_name":"Piet Aarden","orcid":"https://orcid.org/0000-0001-7826-7985","observed_orcids":["https://orcid.org/0000-0001-7826-7985"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Piet Aarden","raw_affiliation_strings":["Novartis Pharma AG , Basel ,","Novartis Pharma AG , Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-7826-7985","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG , Basel ,","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG , Basel , Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038011784","display_name":"Frank Dahlke","orcid":"https://orcid.org/0000-0003-3333-6291","observed_orcids":["https://orcid.org/0000-0003-3333-6291"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Frank Dahlke","raw_affiliation_strings":["Novartis Pharma AG , Basel ,","Novartis Pharma AG , Basel , Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-3333-6291","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG , Basel ,","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG , Basel , Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065754098","display_name":"Douglas Lorne Arnold","orcid":"https://orcid.org/0000-0003-4266-0106","observed_orcids":["https://orcid.org/0000-0003-4266-0106","https://orcid.org/0000-0002-0805-7672"]},"institutions":[{"id":"https://openalex.org/I1292859797","display_name":"Montreal Neurological Institute and Hospital","ror":"https://ror.org/05ghs6f64","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1292859797","https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Douglas L Arnold","raw_affiliation_strings":["McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University , Montr\u00e9al, QC ,","McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University , Montr\u00e9al, QC , Canada"],"raw_orcid":"https://orcid.org/0000-0003-4266-0106","affiliations":[{"raw_affiliation_string":"McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University , Montr\u00e9al, QC ,","institution_ids":["https://openalex.org/I1292859797","https://openalex.org/I5023651"]},{"raw_affiliation_string":"McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University , Montr\u00e9al, QC , Canada","institution_ids":["https://openalex.org/I1292859797","https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038373894","display_name":"Heinz Wiendl","orcid":"https://orcid.org/0000-0003-4310-3432","observed_orcids":["https://orcid.org/0000-0003-4310-3432","https://orcid.org/0000-0001-5509-1075"]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]},{"id":"https://openalex.org/I4210103666","display_name":"University Hospital M\u00fcnster","ror":"https://ror.org/01856cw59","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103666"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heinz Wiendl","raw_affiliation_strings":["Department of Neurology with Institute of Translational Neurology, University Hospital M\u00fcnster , M\u00fcnster ,","Department of Neurology with Institute of Translational Neurology, University Hospital M\u00fcnster , M\u00fcnster , Germany"],"raw_orcid":"https://orcid.org/0000-0003-4310-3432","affiliations":[{"raw_affiliation_string":"Department of Neurology with Institute of Translational Neurology, University Hospital M\u00fcnster , M\u00fcnster ,","institution_ids":["https://openalex.org/I22465464","https://openalex.org/I4210103666"]},{"raw_affiliation_string":"Department of Neurology with Institute of Translational Neurology, University Hospital M\u00fcnster , M\u00fcnster , Germany","institution_ids":["https://openalex.org/I22465464","https://openalex.org/I4210103666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055725062","display_name":"Tanuja Chitnis","orcid":"https://orcid.org/0000-0002-9897-4422","observed_orcids":["https://orcid.org/0000-0002-9897-4422"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanuja Chitnis","raw_affiliation_strings":["Department of Neurology, Brigham and Women\u2019s Hospital , Boston, MA ,","Department of Neurology, Brigham and Women\u2019s Hospital , Boston, MA , USA"],"raw_orcid":"https://orcid.org/0000-0002-9897-4422","affiliations":[{"raw_affiliation_string":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, MA ,","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Department of Neurology, Brigham and Women\u2019s Hospital , Boston, MA , USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056453682","display_name":"Thomas E. Nichols","orcid":"https://orcid.org/0000-0002-4516-5103","observed_orcids":["https://orcid.org/0000-0002-4516-5103"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas E Nichols","raw_affiliation_strings":["Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford , Oxford ,","Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, UK"],"raw_orcid":"https://orcid.org/0000-0002-4516-5103","affiliations":[{"raw_affiliation_string":"Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford , Oxford ,","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108883900","display_name":"Bernd C. Kieseier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Bernd C Kieseier","raw_affiliation_strings":["Novartis Pharma AG , Basel ,","Novartis Pharma AG , Basel , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG , Basel ,","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG , Basel , Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109838419","display_name":"Robert A. Bermel","orcid":"https://orcid.org/0000-0003-2334-6883","observed_orcids":["https://orcid.org/0000-0003-2334-6883"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A Bermel","raw_affiliation_strings":["Department of Neurology, Mellen Center for Multiple Sclerosis, Cleveland Clinic , Cleveland, OH ,","Department of Neurology, Mellen Center for Multiple Sclerosis, Cleveland Clinic , Cleveland, OH , USA"],"raw_orcid":"https://orcid.org/0000-0003-2334-6883","affiliations":[{"raw_affiliation_string":"Department of Neurology, Mellen Center for Multiple Sclerosis, Cleveland Clinic , Cleveland, OH ,","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"Department of Neurology, Mellen Center for Multiple Sclerosis, Cleveland Clinic , Cleveland, OH , USA","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5025501697"],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":{"value":3606,"currency":"GBP","value_usd":4461},"apc_paid":{"value":3606,"currency":"GBP","value_usd":4461},"fwci":59.3502,"has_fulltext":true,"cited_by_count":550,"citation_normalized_percentile":{"value":0.99971213,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"145","issue":"9","first_page":"3147","last_page":"3161"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.871999979019165},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.7540000081062317},{"id":"https://openalex.org/keywords/pira","display_name":"progression independent of relapse activity","score":0.878000020980835},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.8190000057220459},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.9409999847412109},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.8090000152587891},{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/pediatric-multiple-sclerosis","display_name":"pediatric multiple sclerosis","score":0.7990000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7526966333389282},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7391314506530762},{"id":"https://openalex.org/C2780892749","wikidata":"https://www.wikidata.org/wiki/Q929518","display_name":"Expanded Disability Status Scale","level":3,"score":0.7119486331939697},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5935317277908325},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5640959143638611},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4927220642566681},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.48581433296203613},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4535050392150879},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4423692524433136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4155787229537964},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.4129270613193512},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4115350842475891},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3554912209510803},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.16911178827285767},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.15011689066886902},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13131648302078247},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.09394371509552002}],"mesh":[{"descriptor_ui":"D006233","descriptor_name":"Persons with Disabilities","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006233","descriptor_name":"Disabled Persons","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006233","descriptor_name":"Persons with Disabilities","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/brain/awac016","doi":"https://doi.org/10.1093/brain/awac016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/brain/awac016","pdf_url":"https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac016/42358857/awac016.pdf","source":{"id":"https://openalex.org/S118357697","display_name":"Brain","issn_l":"0006-8950","issn":["0006-8950","1460-2156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain","raw_type":"journal-article"},{"id":"pmid:35104840","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35104840","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain : a journal of neurology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9536294","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9536294","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brain","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/brain/awac016","doi":"https://doi.org/10.1093/brain/awac016","is_oa":true,"landing_page_url":"https://doi.org/10.1093/brain/awac016","pdf_url":"https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac016/42358857/awac016.pdf","source":{"id":"https://openalex.org/S118357697","display_name":"Brain","issn_l":"0006-8950","issn":["0006-8950","1460-2156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5400000214576721}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306161","display_name":"National Multiple Sclerosis Society","ror":"https://ror.org/03019wv17"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320309052","display_name":"Alexion Pharmaceuticals","ror":"https://ror.org/031ywxc85"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320312570","display_name":"Jazz Pharmaceuticals","ror":"https://ror.org/055mhsv54"},{"id":"https://openalex.org/F4320313971","display_name":"TG Therapeutics","ror":"https://ror.org/00pwykz63"},{"id":"https://openalex.org/F4320314782","display_name":"GW Pharmaceuticals","ror":"https://ror.org/01gtctx88"},{"id":"https://openalex.org/F4320315053","display_name":"Acorda Therapeutics","ror":"https://ror.org/01788sq40"},{"id":"https://openalex.org/F4320316469","display_name":"Atara Biotherapeutics","ror":"https://ror.org/04h82wq77"},{"id":"https://openalex.org/F4320316473","display_name":"Mylan","ror":"https://ror.org/04nsw4151"},{"id":"https://openalex.org/F4320318412","display_name":"Argenx","ror":"https://ror.org/04spfxf63"},{"id":"https://openalex.org/F4320320084","display_name":"Multiple Sclerosis Society","ror":"https://ror.org/043fwdk81"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320321114","display_name":"Bundesministerium f\u00fcr Bildung und Forschung","ror":"https://ror.org/04pz7b180"},{"id":"https://openalex.org/F4320321959","display_name":"Gemeinn\u00fctzige Hertie-Stiftung","ror":"https://ror.org/03ak9vt35"},{"id":"https://openalex.org/F4320325166","display_name":"Schweizerische Multiple Sklerose Gesellschaft","ror":"https://ror.org/015zgf178"},{"id":"https://openalex.org/F4320329429","display_name":"Idorsia Pharmaceuticals","ror":"https://ror.org/03va9ng43"},{"id":"https://openalex.org/F4320330529","display_name":"MedDay Pharmaceuticals","ror":"https://ror.org/01taed346"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4210695280.pdf","grobid_xml":"https://content.openalex.org/works/W4210695280.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W1974000699","https://openalex.org/W1979835871","https://openalex.org/W1982614515","https://openalex.org/W1982881050","https://openalex.org/W1986991730","https://openalex.org/W1987053154","https://openalex.org/W2016524113","https://openalex.org/W2024251669","https://openalex.org/W2034896241","https://openalex.org/W2036863084","https://openalex.org/W2037636284","https://openalex.org/W2043093575","https://openalex.org/W2054553592","https://openalex.org/W2080852206","https://openalex.org/W2104948944","https://openalex.org/W2112165124","https://openalex.org/W2121287780","https://openalex.org/W2138115784","https://openalex.org/W2148455753","https://openalex.org/W2153466844","https://openalex.org/W2156268561","https://openalex.org/W2157840043","https://openalex.org/W2158059667","https://openalex.org/W2158515030","https://openalex.org/W2184753479","https://openalex.org/W2267348707","https://openalex.org/W2326826867","https://openalex.org/W2338386937","https://openalex.org/W2345469235","https://openalex.org/W2474020503","https://openalex.org/W2512303823","https://openalex.org/W2561881161","https://openalex.org/W2790022230","https://openalex.org/W2804123946","https://openalex.org/W2806791998","https://openalex.org/W2890515892","https://openalex.org/W2914396477","https://openalex.org/W2922528121","https://openalex.org/W2937722524","https://openalex.org/W2960090157","https://openalex.org/W3010457503","https://openalex.org/W3033968144","https://openalex.org/W3051923090","https://openalex.org/W3121899751","https://openalex.org/W3163782443","https://openalex.org/W3168177144","https://openalex.org/W3212935286"],"related_works":["https://openalex.org/W2025909013","https://openalex.org/W2940753023","https://openalex.org/W4290988590","https://openalex.org/W4238477398","https://openalex.org/W2394374926","https://openalex.org/W2994686985","https://openalex.org/W3140447077","https://openalex.org/W2525470836","https://openalex.org/W1966515383","https://openalex.org/W2228388786"],"abstract_inverted_index":{"Patients":[0],"with":[1,81,253,281,304,328,330,340,403],"multiple":[2,44,53,60,65,306,359,365,416],"sclerosis":[3,45,54,61,366],"acquire":[4],"disability":[5,27,48,104,149,172,196,212,237,255,373,380,391,399],"either":[6],"through":[7],"relapse-associated":[8],"worsening":[9,28,150,162,213],"(RAW)":[10],"or":[11],"progression":[12,37],"independent":[13],"of":[14,24,32,138,145,158,161,195,202,210,320,354,372,395,415],"relapse":[15,248],"activity":[16],"(PIRA).":[17],"This":[18],"study":[19],"addresses":[20],"the":[21,30,33,40,51,135,143,156,159,167,183,192,199,203,208,227,242,333,352,369,376,385,404,412],"relative":[22,136],"contribution":[23],"relapses":[25,106,146,220,349],"to":[26,42,169,273,313,322,351,406],"over":[29],"course":[31],"disease,":[34],"how":[35],"early":[36,181,357],"begins":[38,362],"and":[39,63,97,105,122,140,154,163,190,238,270,296,342,367,381],"extent":[41],"which":[43,103,219],"therapies":[46,165,283,397],"delay":[47],"accumulation.":[49,392],"Using":[50],"Novartis-Oxford":[52],"(NO.MS)":[55],"data":[56,346],"pool":[57],"spanning":[58],"all":[59,95,114,124,188],"phenotypes":[62,189],"paediatric":[64],"sclerosis,":[66,307],"we":[67],"evaluated":[68],"\u223c200":[69],"000":[70,79],"Expanded":[71],"Disability":[72],"Status":[73],"Scale":[74],"(EDSS)":[75],"transitions":[76,335],"from":[77],">27":[78],"patients":[80,252,280,303,339],"\u226415":[82],"years":[83,261,272,290,298],"follow-up.":[84],"We":[85,133],"analysed":[86],"three":[87],"datasets:":[88],"(i)":[89],"A":[90],"full":[91],"analysis":[92],"dataset":[93],"containing":[94],"observational":[96],"randomized":[98],"controlled":[99],"clinical":[100,117,128],"trials":[101,118,129],"in":[102,182,187,198,218,265,338,358,363,411],"were":[107,241,336],"assessed":[108],"(n":[109,119,130],"=":[110,120,131],"27":[111],"328);":[112],"(ii)":[113],"phase":[115,126,201],"3":[116,127],"8346);":[121],"(iii)":[123],"placebo-controlled":[125],"4970).":[132],"determined":[134],"importance":[137],"RAW":[139,314],"PIRA,":[141],"investigated":[142],"role":[144],"on":[147,166],"all-cause":[148,211],"using":[151,174],"Andersen-Gill":[152],"models":[153],"observed":[155,337],"impact":[157],"mechanism":[160],"disease-modifying":[164,282,396],"time":[168,175,321,408],"reach":[170,323],"milestone":[171,324],"levels":[173],"continuous":[176],"Markov":[177],"models.":[178],"PIRA":[179,331,341,361],"started":[180],"disease":[184,377],"process,":[185],"occurred":[186,221],"became":[191],"principal":[193,243,386],"driver":[194,371],"accumulation":[197,353,374],"progressive":[200],"disease.":[204],"Relapses":[205],"significantly":[206,287],"increased":[207,229,263],"hazard":[209,228],"events;":[214,332],"following":[215],"a":[216,223,317],"year":[217,224],"(versus":[222],"without":[225],"relapses),":[226],"by":[230,288,401],"31-48%":[231],"(all":[232],"P":[233],"<":[234],"0.001).":[235],"Pre-existing":[236,379],"older":[239,382],"age":[240,383],"risk":[244,387],"factors":[245,388],"for":[246,389],"incomplete":[247],"recovery.":[249],"For":[250],"placebo-treated":[251],"minimal":[254],"(EDSS":[256,268,277],"1),":[257],"it":[258],"took":[259,316],"8.95":[260],"until":[262],"limitation":[264],"walking":[266,275],"ability":[267],"4)":[269],"18.48":[271],"require":[274],"assistance":[276],"6).":[278],"Treating":[279],"delayed":[284],"these":[285],"times":[286],"3.51":[289],"(95%":[291],"confidence":[292],"limit:":[293],"3.19,":[294],"3.96)":[295],"3.09":[297],"(2.60,":[299],"3.72),":[300],"respectively.":[301],"In":[302],"relapsing-remitting":[305,364],"those":[308,329],"who":[309],"worsened":[310],"exclusively":[311],"due":[312],"events":[315],"similar":[318],"length":[319],"EDSS":[325],"values":[326],"compared":[327],"fastest":[334],"superimposed":[343],"relapses.":[344],"Our":[345],"confirm":[347],"that":[348],"contribute":[350],"disability,":[355],"primarily":[356],"sclerosis.":[360,417],"becomes":[368],"dominant":[370],"as":[375],"evolves.":[378],"are":[384],"further":[390],"The":[393],"use":[394],"delays":[398],"accrual":[400],"years,":[402],"potential":[405],"gain":[407],"being":[409],"highest":[410],"earliest":[413],"stages":[414]},"counts_by_year":[{"year":2026,"cited_by_count":123},{"year":2025,"cited_by_count":157},{"year":2024,"cited_by_count":158},{"year":2023,"cited_by_count":88},{"year":2022,"cited_by_count":19}],"updated_date":"2026-10-26T11:51:55.731654","created_date":"2025-10-10T00:00:00"}